Why the study?
Multiple guidelines address the perioperative management of antiplatelet and anticoagulant drugs, but unresolved problems and novel approaches warrant evaluation across non-cardiac, cardiac, and regional anesthesia.
This review provides an updated summary of perioperative management guidelines for patients on antithrombotic therapy, emphasizing specific discontinuation timelines and the lack of benefit for bridging therapy.
No takes yet. Share an insight, caveat, or question.
May inform perioperative antithrombotic protocols without bridging; leaves open prospective validation in diverse surgical cohorts.
Moster et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: